Page last updated: 2024-09-03

gefitinib and Injuries, Spinal Cord

gefitinib has been researched along with Injuries, Spinal Cord in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, B; Dai, J; Dong, Q; Fan, C; Fan, Y; Fang, Y; Han, J; Han, S; Li, X; Liu, S; Liu, W; Ma, D; Wu, X; Xiao, Z; Xu, B; Xue, W; Xue, X; Yang, Y; Zhang, H; Zhao, Y1

Other Studies

1 other study(ies) available for gefitinib and Injuries, Spinal Cord

ArticleYear
Epidermal growth factor receptor-extracellular-regulated kinase blockade upregulates TRIM32 signaling cascade and promotes neurogenesis after spinal cord injury.
    Stem cells (Dayton, Ohio), 2020, Volume: 38, Issue:1

    Topics: Animals; Cells, Cultured; Cetuximab; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Gefitinib; GTP-Binding Proteins; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord Injuries; Up-Regulation

2020